Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
NCT00004360 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2005-06-24
Summary
OBJECTIVES:
I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus.
Conditions
- Diabetes Insipidus, Nephrogenic
Interventions
- DRUG
-
chlorothiazide
Sponsors & Collaborators
- collaborator OTHER
-
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Gary L. Robertson · Northwestern University
Eligibility
- Min Age
- 6 Months
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1995-09-30
More Related Trials
-
Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
NCT01764711 ·Status: COMPLETED ·Phase: NA
-
Evaluation of A Clinical Diagnostic Test for CRDS
NCT06188689 ·Status: RECRUITING ·Phase: NA
-
Use of Copeptin in Diabetes Insipidus
NCT01940614 ·Status: COMPLETED
-
Dyskinesia, Heterotaxy and Congenital Heart Disease
NCT00608556 ·Status: COMPLETED
-
Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study
NCT03572166 ·Status: COMPLETED ·Phase: NA
-
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
NCT02432079 ·Status: RECRUITING
-
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004669 ·Status: COMPLETED ·Phase: PHASE2
-
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810 ·Status: COMPLETED
-
Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome
NCT00286910 ·Status: COMPLETED
-
Spironolactone Improved Children With Gene Mutations Related to NCOR
NCT06678685 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
NCT00004312 ·Status: COMPLETED
-
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
NCT00000102 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
NCT02368379 ·Status: COMPLETED ·Phase: NA
-
Nesiritide in Chronic Heart Failure
NCT00145873 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of the Administration of Fludrocortisone in Very Premature Infants
NCT03001089 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
NCT05287022 ·Status: RECRUITING
-
Endothelial Hyperpolarization in Humans
NCT00166166 ·Status: TERMINATED ·Phase: PHASE2
-
Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
NCT01839812 ·Status: COMPLETED ·Phase: PHASE1
-
Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study
NCT01439997 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Males With Creatine Transporter Deficiency
NCT02931682 ·Status: TERMINATED
-
Genetics of Congenital Heart Disease
NCT01192048 ·Status: RECRUITING
-
Tolvaptan Versus Fluid Restriction in SIADH
NCT04119206 ·Status: COMPLETED
-
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia
NCT01108770 ·Status: COMPLETED
-
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
NCT03326037 ·Status: UNKNOWN
-
Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
NCT04011566 ·Status: RECRUITING